Bone Marrow TransplantationTissue DonorsHistocompatibility TestingTransplantation, HomologousBlood DonorsGraft vs Host DiseaseBone MarrowHistocompatibilityBone Marrow CellsGraft SurvivalTransplantation ChimeraWhole-Body IrradiationTransplantation ConditioningAnemia, AplasticTransplantation, AutologousLeukemiaHematopoietic Stem Cell TransplantationSurvival AnalysisHematopoietic Stem CellsGraft RejectionFetal BloodBone and BonesHLA AntigensLeukocyte TransfusionRadiation ChimeraTransplantation, IsogeneicLiver TransplantationGraft Enhancement, ImmunologicLiving DonorsTransplantation ToleranceImmunosuppressionKidney TransplantationRecurrenceMice, Inbred C57BLBone Marrow PurgingLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTime FactorsTreatment OutcomeImmunosuppressive AgentsBusulfanBone Marrow DiseasesSkin TransplantationT-LymphocytesTransplantation ImmunologyLymphocyte DepletionGraft vs Host ReactionAcute DiseaseHematopoiesisChimerismHematologic NeoplasmsPrecursor Cell Lymphoblastic Leukemia-LymphomaTissue and Organ ProcurementBone Marrow ExaminationCyclophosphamideHeart TransplantationActuarial AnalysisBone Marrow NeoplasmsLeukemia, Myeloid, AcuteCombined Modality TherapyColony-Forming Units AssayRetrospective StudiesLymphocyte Culture Test, MixedRemission InductionSpinal CordChimeraDisease-Free SurvivalMice, Inbred BALB CCord Blood Stem Cell TransplantationLeukemia, MyeloidStem Cell TransplantationHepatic Veno-Occlusive DiseaseBone RemodelingAntigens, CD34Blood BanksCell DifferentiationFlow CytometryLymphoma, Non-HodgkinLymphocyte TransfusionMyelodysplastic SyndromesSevere Combined ImmunodeficiencyCells, CulturedHematologic DiseasesSurvival RateBlood TransfusionLung TransplantationCyclosporineMice, Inbred C3HSpleenLeukocyte CountCytomegalovirus InfectionsImmune TolerancePancytopeniaFollow-Up StudiesNuclear FamilyBone DensityGranulocyte Colony-Stimulating FactorOrgan TransplantationAntineoplastic Combined Chemotherapy ProtocolsImmunophenotypingGraft vs Tumor Effect